Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-46.57	15.42	28.87
Graham Fair Price	-22.02	5.47	7.01
PEG	82.40	-0.27	-1.51
Price/Book	-34.59	1.00	1.53
Price/Cash Flow	-78.17	-16.89	77.35
Prices/Earnings	12.63	10.65	9.46
Price/Sales	-26.39	4.54	6.17
Price/FCF	-78.17	-16.89	77.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	28.62	0.23	0.18
Operating Margin	-15.89	0.13	0.15
ROA	-40.98	0.01	0.02
ROE	0.04	0.02	-41.92
ROIC	0.03	0.02	-35.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	-0.01	-458.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	-0.24	-23.83
EPS QOQ	-0.06	-0.40	-540.00
FCF QOQ	1.35	-4.07	201.25
Revenue QOQ	0.02	-0.09	441.29
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	124.47	150.37	20.80
Days Sales Outstanding (DSO)	76.21	58.59	-23.11
Inventory Turnover	0.72	0.60	-17.22
Debt/Capitalization	0.21	0.20	-6.86
Quick Ratio	0.87	0.74	-15.12
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.35	7.52	2.32
Cash	3.08	2.69	-12.62
Capex	-0.77	-0.80	-4.53
Free Cash Flow	0.15	-0.45	206.58
Revenue	1.82	1.65	-9.08
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.25	1.22	-2.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.06	-1.89	38.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating